Capital World Investors Ironwood Pharmaceuticals Inc Transaction History

Capital World Investors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$9.04 - $11.86 $18.4 Million - $24.1 Million	-2,030,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$11.13 - $13.63 $7.79 Million - $9.54 Million	700,000 Added 52.63%	2,030,000 $31.3 Million
Q3 2017 Nov 14, 2017	BUY	$12.07 - $14.87 $16.1 Million - $19.8 Million	1,330,000	1,330,000 $21 Million

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $513M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.